Literature DB >> 12524556

Neuromyelitis optica.

Bruce A C Cree1, Douglas S Goodin, Stephen L Hauser.   

Abstract

Whether neuromyelitis optica (NMO), the co-occurrence of myelitis and optic neuritis, is a variant of multiple sclerosis (MS) or a unique disease is controversial. Distinct neuropathological features and a fulminant clinical course argue in favor of NMO as a distinct disease. However, the combination of neurological impairments of myelitis and optic neuritis occurs in patients with several inflammatory disorders, including multiple sclerosis and collagen vascular diseases. NMO is also associated with certain infectious diseases. The fact that the NMO phenotype occurs in a variety of disease states suggests that NMO does not represent a specific clinical entity. To better understand NMO and its associations with recognized diseases, a systematic review of the literature using MEDLINE was conducted. The history of NMO, its nosology, associations with other diseases, and current concepts of its pathogenesis and treatment is reviewed in this article.

Entities:  

Mesh:

Year:  2002        PMID: 12524556     DOI: 10.1055/s-2002-36534

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  33 in total

1.  Illuminating neuromyelitis optica pathogenesis.

Authors:  Richard M Ransohoff
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-23       Impact factor: 11.205

Review 2.  Loss of vision: imaging the visual pathways.

Authors:  H R Jäger
Journal:  Eur Radiol       Date:  2005-01-26       Impact factor: 5.315

3.  AQP4 antibody-positive Thai cases: clinical features and diagnostic problems.

Authors:  S Siritho; I Nakashima; T Takahashi; K Fujihara; N Prayoonwiwat
Journal:  Neurology       Date:  2011-08-03       Impact factor: 9.910

4.  Differentiation of neuromyelitis optica from multiple sclerosis on spinal magnetic resonance imaging.

Authors:  Saurabh Lalan; Majid Khan; Bruce Schlakman; Alan Penman; Joseph Gatlin; Robert Herndon
Journal:  Int J MS Care       Date:  2012

Review 5.  Update on neuromyelitis optica: natural history and management.

Authors:  Panitha Jindahra; T Plant
Journal:  Eye Brain       Date:  2012-03-26

Review 6.  Heterogeneity in oligodendroglia: Is it relevant to mouse models and human disease?

Authors:  Isis M Ornelas; Lauren E McLane; Aminat Saliu; Angelina V Evangelou; Luipa Khandker; Teresa L Wood
Journal:  J Neurosci Res       Date:  2016-08-25       Impact factor: 4.164

7.  Visualization of inflammation and demyelination in 2D2 transgenic mice with rodent MRI.

Authors:  Jordan C Bell; Qingwei Liu; Yan Gan; Qiang Liu; Yaou Liu; Fu-Dong Shi; Gregory H Turner
Journal:  J Neuroimmunol       Date:  2013-09-18       Impact factor: 3.478

8.  Aquaporin-4 autoantibodies in neuromyelitis optica spectrum disorders: comparison between tissue-based and cell-based indirect immunofluorescence assays.

Authors:  Koon H Chan; Jason S C Kwan; Philip W L Ho; Jessica W M Ho; Andrew C Y Chu; David B Ramsden
Journal:  J Neuroinflammation       Date:  2010-09-07       Impact factor: 8.322

Review 9.  CD19 as a molecular target in CNS autoimmunity.

Authors:  Olaf Stüve; Clemens Warnke; Krystin Deason; Martin Stangel; Bernd C Kieseier; Hans-Peter Hartung; Hans-Christian von Büdingen; Diego Centonze; Thomas G Forsthuber; Volker Knappertz
Journal:  Acta Neuropathol       Date:  2014-07-04       Impact factor: 17.088

10.  Optic Neuritis: The Role of Disease-modifying Therapy in This Clinically Isolated Syndrome.

Authors:  Fiona Costello
Journal:  Curr Treat Options Neurol       Date:  2007-01       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.